CORCEPT THERAPEUTICS INC (CORT)
Pharmaceutical Preparations
Latest Price
$114.49
TTM P/E
327.11
Normalized P/E
133.95
Div Yield
--
Book Value
6.11
P/B Ratio
18.74
Valuation metrics
adjust assumptions →EPS: $0.82
Book value / share: $6.11
Formula: √(22.5 × EPS × BVPS)
Graham Number
$10.62
91% downside
Norm. op. income: $113M (median of 7yr)
Tax rate: 14%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$12.68
89% downside
Base FCF: $142M (median of recent 5yr)
Growth: 8%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$32.98
71% downside
EPS: $0.82
Target P/E: 15×
Formula: EPS × P/E
P/E Fair Value
$12.30
89% downside
Institutional Ownership
75.9% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 12.15M | $489.0M | 11.64% | +89.1K | 2026-03-31 |
| INGALLS & SNYDER LLC | 7.61M | $306.0M | 7.29% | +413.7K | 2026-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 5.68M | $229.0M | 5.44% | -75.7K | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.82M | $194.0M | 4.62% | -- | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.08M | $164.0M | 3.90% | -- | 2026-03-31 |
| Parallel Advisors, LLC | 3.98M | $160.0M | 3.81% | +98.3K | 2026-03-31 |
| STATE STREET CORP | 3.20M | $129.0M | 3.07% | +214.9K | 2026-03-31 |
| FMR LLC | 3.19M | $128.0M | 3.05% | +775.6K | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.71M | $109.0M | 2.60% | +44.6K | 2026-03-31 |
| FIRST TRUST ADVISORS LP | 2.17M | $87.0M | 2.08% | +1.48M | 2026-03-31 |